Stay updated on Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.
Latest updates to the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check13 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check49 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check64 days agoChange DetectedOn November 22, 2024, new content was added, while a significant section detailing data download options and study information was removed on October 10, 2023.SummaryDifference15%
- Check71 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
Stay in the know with updates to Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.